systemic sclerosis ild | Systemic sclerosis-associated interstitial lu

Keyword	CPC	PCC	Volume	Score	Length of keyword
systemic sclerosis ild	0.54	0.2	5692	30	22
systemic	0.45	0.6	6862	100	8
sclerosis	0.38	0.7	9147	6	9
ild	0.79	0.5	5158	34	3

Keyword	CPC	PCC	Volume	Score
systemic sclerosis ild	0.56	0.6	5946	38
systemic sclerosis sildenafil	1.75	0.5	3830	50
systemic sclerosis induced by medication	0.69	0.3	4549	29
systemic sclerosis icd 10	1.09	0.7	6314	62
systemic sclerosis life expectancy	0.86	1	1016	77
systemic sclerosis lung	1.31	0.4	7718	31
systemic sclerosis and multiple sclerosis	1.44	0.3	2744	79
systemic sclerosis and pulmonary hypertension	1.3	0.8	3189	100
systemic sclerosis and dysphagia	0.38	0.8	5084	1
systemic sclerosis lancet	1.38	1	4991	87
systemic sclerosis lung ct	0.55	0.3	931	29
systemic sclerosis and scleroderma	0.99	0.6	4463	22
systemic sclerosis lung disease	0.54	0.8	7635	9
systemic sclerosis lung radiology	0.19	1	5050	68
systemic sclerosis associated ild	0.46	0.7	9904	42
systemic sclerosis and ild	1.04	0.4	6034	90

Search Results related to systemic sclerosis ild on Search Engine

Systemic sclerosis-associated interstitial lung disease
thelancet.com

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30480-1/fulltext

WEBCurrently, interstitial lung disease is the most common cause of death among patients with systemic sclerosis, with a prevalence of up to 30% and a 10-year mortality of up to 40%. Systemic sclerosis-associated interstitial lung disease - …

DA: 40 PA: 41 MOZ Rank: 6

Treatment and prognosis of interstitial lung disease in systemic
uptodate.com

https://www.uptodate.com/contents/treatment-and-prognosis-of-interstitial-lung-disease-in-systemic-sclerosis-scleroderma

WEBFeb 8, 2024 · Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) that is often progressive and has a poor prognosis [ 1-7 ]. SSc-associated ILD consists of various histopathologic subtypes, most commonly nonspecific interstitial pneumonitis and usual interstitial pneumonitis.

DA: 21 PA: 82 MOZ Rank: 21

SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730677/

WEBSummary: Systemic sclerosis (SSc; scleroderma) has the highest individual mortality of all rheumatic diseases and interstitial lung disease (ILD) is among the leading causes of SSc-related death.

DA: 91 PA: 18 MOZ Rank: 49

Systemic sclerosis-associated interstitial lung disease
nih.gov

https://pubmed.ncbi.nlm.nih.gov/32113575/

WEBSystemic sclerosis-associated interstitial lung disease most commonly presents with dyspnoea, cough, and a non-specific interstitial pneumonia pattern on CT scan, with a minority of cases fulfilling the criteria for usual interstitial pneumonia.

DA: 76 PA: 89 MOZ Rank: 33

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339436/

WEBJan 18, 2019 · Systemic sclerosis (SSc) is a rare connective tissue disease with a heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of SSc and a leading cause of death.

DA: 67 PA: 61 MOZ Rank: 50

Expert consensus on the management of systemic sclerosis …
biomedcentral.com

https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-022-02292-3

WEBJan 9, 2023 · Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for 20–40% of mortality. Evolution of therapeutic options has resulted in a lack of consensus on how to manage this condition.

DA: 81 PA: 74 MOZ Rank: 58

Treatment of Systemic Sclerosis–associated Interstitial Lung Disease
atsjournals.org

https://www.atsjournals.org/doi/abs/10.1164/rccm.202306-1113ST

WEBBackground: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding treatment for patients with SSc-ILD are primarily consensus based.

DA: 92 PA: 13 MOZ Rank: 73

Interstitial Lung Disease in Systemic Sclerosis: Focus on Early
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910104/

WEBDec 9, 2019 · Abstract. Systemic sclerosis (SSc) is a progressive and often devastating disease characterized by autoimmune dysfunction, vasculopathy, and fibrosis. Interstitial lung disease (ILD) is identified in the majority of patients with SSc and is the leading cause of SSc-related mortality.

DA: 3 PA: 92 MOZ Rank: 70

Systemic sclerosis interstitial lung disease: unmet needs and
nature.com

https://www.nature.com/articles/s41584-023-01044-x

WEBNov 3, 2023 · Systemic sclerosis (SSc), or scleroderma, is a rare, systemic autoimmune disease that is associated with high mortality, often resulting from cardiopulmonary complications such as...

DA: 99 PA: 23 MOZ Rank: 87

Consensus statements for managing systemic sclerosis …
thelancet.com

https://www.thelancet.com/pdfs/journals/lanrhe/PIIS2665-9913(20)30003-5.pdf

WEBSystemic sclerosis associated ILD poses challenges in determining who to treat and when. Approximately 10% of patients develop pulmonary arterial hypertension, and vasodilator therapy can be justified in almost all patients. By contrast, ILD occurs in up to 90% of patients, usually in the first 3–4 years after onset of systemic sclerosis.

DA: 28 PA: 63 MOZ Rank: 44